Francesca Barone, Chief Scientific Officer at Candel Therapeutics, Inc. (CADL), sold 25,290 shares at $5.97 ($151K) on 2024-07-11, disclosed to the SEC on 2024-07-15.
Open-market sale of $151k CADL by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.97 | 12,645 | $75K | 50.0% |
| 2 | $5.97 | 12,645 | $75K | 50.0% |
| Total | $5.97 avg | 25,290 | $151K | 100% |
| Filing → |
| CADL | SELL | 2025-01-17 | $196K | — | Filing → |
| CADL | SELL | 2025-01-10 | $225K | — | Filing → |
| CADL | SELL | 2024-12-03 | $201K | — | Filing → |